Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Re: Utility of routine preoperative (18)F-fluorodeoxyglucose positron emission tomography/computerized tomography in identifying pathological lymph node metastases at radical cystectomy - Reply by authors
    Correspondence

    Dason, S.; Wong, N. C.; Donahue, T. F.; Meier, A.; Zheng, J.; Mannelli, L.; Di Paolo, P. L.; Dean, L. W.; McPherson, V. A.; Rosenberg, J. E.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Survival with tabelecleucel in patients with Epstein-Barr virus-driven post-transplant lymphoproliferative disease after solid organ transplant
    Meeting Abstract

    Prockop, S.; Gamelin, L.; Dinavahi, R.; Sun, Y.; Guzman-Becerra, N.; Parmar, H.
    Transplant International (2021)

    Fulltext@MSK | Save
  • Selection matters: Addressing biases in linked clinico-genomic data sets
    Meeting Abstract

    Panageas, K.; Kehl, K. L.; Incerti, D.; Stürmer, T.
    Pharmacoepidemiology and Drug Safety (2021)

    Fulltext@MSK | Save
  • Assessment of oncofertility content on reproductive endocrinology and infertility clinic websites
    Meeting Abstract

    Mujumdar, V.; Shivashankar, K.; Madding, R.; Levy, A.; Richard, S.; Gordhandas, S.; Rosenblum, N.; Monseur, B.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Breast nodule in a male-to-female transgender (MFT) adolescent
    Meeting Abstract

    Essoh, S.; Kallakuri, A.; Heerdt, A.; Ten, S.
    Hormone Research in Paediatrics (2021)

    Fulltext@MSK | Save
  • TERT promoter mutations associated with longer progression-free and overall survival under BRAF/MEK therapy
    Meeting Abstract

    Thielmann, C. M.; Matull, J.; Zaremba, A.; Murali, R.; Chorti, E.; Lodde, G.; Jansen, P.; Herbst, R.; Terheyden, P.; Utikal, J. S.; more...
    Journal Der Deutschen Dermatologischen Gesellschaft (2021)

    Fulltext@MSK | Save
  • Morphological subtyping of breast cancer using machine learning
    Meeting Abstract

    Hanna, M.; Lee, M.; Bozkurt, A.; Hamilton, P.; Godrich, R.; Casson, A.; Raciti, P.; Sue, J.; Viret, J.; Lee, D.; more...
    Journal of Pathology (2021)

    Fulltext@MSK | Save
  • Belantamab mafodotin (belamaf; GSK2857916) US expanded access program (EAP) for heavily pre-treated patients with relapsed/refractory multiple myeloma (RRMM): Baseline characteristics
    Meeting Abstract

    Hultcrantz, M.; Anderson, L. D. Jr; Anwer, F.; Gasparetto, C.; Kocoglu, M. H.; Lichtman, E. I.; Mo, C.; Niesvizky, R.; Lewis, E.; Li, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • MagnetisMM-1: A study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-targeted, CD3-engaging bispecific antibody, for patients with relapsed or refractory multiple myeloma (MM)
    Meeting Abstract

    Levy, M.; Bahlis, N.; Raje, N.; Costello, C.; Dholaria, B.; Solh, M.; Tomasson, M.; Dube, H.; Damore, M.; Lon, H. K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • A tumor-agnostic TCR-mimic CAR-T cell specific for NDC80 targets multiple hematological malignancies
    Meeting Abstract

    Klatt, M. G.; Dao, T.; Yang, Z.; Liu, J.; Mun, S. S.; Dacek, M. M.; Luo, H.; Gardner, T. J.; Bourne, C.; Peraro, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save